Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.57 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.41 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.34 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.34 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.34 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.34 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.34 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL2027060 | 1.00 | TDP1 (0.57) | TDP1TSHRALDH1A1HSD17B10SMN1; SMN2 | |
| SCHEMBL166227 | 0.98 | TDP1 (0.59) | TDP1TSHRALDH1A1HSD17B10SMN1; SMN2 | |
| SCHEMBL29362912 | 0.98 | TDP1 (0.59) | TDP1TSHRALDH1A1HSD17B10SMN1; SMN2 | |
| SCHEMBL331712 | 0.96 | TDP1 (0.57) | TDP1TSHRALDH1A1HSD17B10SMN1; SMN2 | |
| SCHEMBL313977 | 0.96 | TDP1 (0.57) | TDP1TSHRALDH1A1HSD17B10SMN1; SMN2 | |
| SCHEMBL2119493 | 0.96 | TDP1 (0.57) | TDP1TSHRALDH1A1HSD17B10SMN1; SMN2 | |
| SCHEMBL7520300 | 0.82 | TDP1 (0.54) | TDP1TSHRALDH1A1HSD17B10SMN1; SMN2 | |
| SCHEMBL6254180 | 0.82 | LMNA (0.48) | TDP1TSHRALDH1A1SMN1; SMN2TP53 | |
| SCHEMBL30541813 | 0.81 | TDP1 (0.41) | TDP1TSHRALDH1A1HSD17B10SMN1; SMN2 | |
| SCHEMBL1373920 | 0.80 | ALDH1A1 (0.53) | TDP1TSHRALDH1A1HSD17B10SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122095475-A | Power unit comprising different droplets separated by amphiphilic membranes | — | 2026-05-26 | — | — | CN | disclosed |
| WO-2025127086-A1 | ALLERGEN-REDUCING PARTICLES, ALLERGEN-REDUCING COATING MATERIAL, AND ALLERGEN-REDUCING PRODUCT | 積水化学工業株式会社 | 2025-06-19 | — | — | WO | disclosed |
| CN-119971053-A | Viral infection inhibitor and viral infection inhibitor product | 积水化学工业株式会社 | 2025-05-13 | — | — | CN | disclosed |
| CN-119836231-A | Virus infection inhibitor, resin composition, master batch for molding synthetic resin, and virus infection inhibitor product | 积水化学工业株式会社 | 2025-04-15 | — | — | CN | disclosed |
| WO-2025046221-A1 | POWER UNIT COMPRISING DISTINCT DROPLETS SEPARATED BY AN AMPHIPHILIC MEMBRANE | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2025-03-06 | — | — | WO | disclosed |
| CN-117042606-B | Virus infection suppressing particles and virus infection suppressing product | 积水化学工业株式会社 | 2025-02-18 | — | — | CN | disclosed |
| CN-117015305-B | Viral infection inhibitor and viral infection inhibitor product | 积水化学工业株式会社 | 2025-02-14 | — | — | CN | disclosed |
| CN-118450802-A | Viral infection suppressing member | 积水化学工业株式会社 | 2024-08-06 | — | — | CN | disclosed |
| CN-118201494-A | Viral infection inhibitor and viral infection inhibitor product | 积水化学工业株式会社 | 2024-06-14 | — | — | CN | disclosed |
| WO-2024034650-A1 | VIRAL INFECTION INHIBITOR, RESIN COMPOSITION, AND VIRAL INFECTION INHIBITORY PRODUCT | 積水化学工業株式会社 | 2024-02-15 | — | — | WO | disclosed |
| CN-117015305-A | Viral infection inhibitor and viral infection inhibitor product | 积水化学工业株式会社 | 2023-11-07 | — | — | CN | disclosed |
| WO-2023171557-A1 | VIRAL INFECTION-INHIBITING MEMBER | 積水化学工業株式会社 | 2023-09-14 | — | — | WO | disclosed |
| WO-2023074805-A1 | VIRAL INFECTION INHIBITOR AND VIRAL INFECTION INHIBITORY PRODUCT | 積水化学工業株式会社 | 2023-05-04 | — | — | WO | disclosed |
| WO-2022244814-A1 | FUNCTIONAL ARTICLE, ACTIVE INGREDIENT CONFIRMATION METHOD, AND COATING LIQUID | 積水マテリアルソリューションズ株式会社 | 2022-11-24 | — | — | WO | disclosed |
| WO-2022191321-A1 | VIRUS INFECTION INHIBITION PARTICLES AND VIRUS INFECTION INHIBITION PRODUCT | 積水化学工業株式会社 | 2022-09-15 | — | — | WO | disclosed |
| WO-2022191322-A1 | VIRAL INFECTION INHIBITOR AND VIRAL INFECTION-INHIBITING PRODUCT | 積水化学工業株式会社 | 2022-09-15 | — | — | WO | disclosed |
| US-20150164070-A1 | INFLUENZA VIRUS INFECTION INHIBITOR FOR FIBER PROCESSING, FIBER PRODUCT USING THE SAME, AND METHOD FOR PRODUCING THE SAME | SEKISUI CHEMICAL CO., LTD. (JP) | 2015-06-18 | — | — | US | disclosed |
| US-8444961-B2 | RNA virus infection inhibitor, method for inhibition of infection by RNA virus, RNA virus infection-inhibiting product, and use as RNA virus infection inhibitor | SEKISUI CHEMICAL CO., LTD. (JP) | 2013-05-21 | — | — | US | disclosed |
| EP-2444095-A1 | RNA VIRUS INFECTION INHIBITOR, METHOD FOR INHIBITION OF INFECTION BY RNA VIRUS, PRODUCTS FOR INHIBITION OF INFECTION BY RNA VIRUS, AND USE AS RNA VIRUS INFECTION INHIBITOR | Sekisui Chemical Co., Ltd. (JP) | 2012-04-25 | — | — | EP | disclosed |
| US-20120093763-A1 | RNA VIRUS INFECTION INHIBITOR, METHOD FOR INHIBITION OF INFECTION BY RNA VIRUS, RNA VIRUS INFECTION-INHIBITING PRODUCT, AND USE AS RNA VIRUS INFECTION INHIBITOR | SEKISUI CHEMICAL CO., LTD. (JP) | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150164070-A1 | INFLUENZA VIRUS INFECTION INHIBITOR FOR FIBER PROCESSING, FIBER PRODUCT USING THE SAME, AND METHOD FOR PRODUCING THE SAME | TFPI, TFPI2, MYO1G | TDP1 3671/4885TSHR 4106/4885ALDH1A1 2436/4885 |
| US-20120093763-A1 | RNA VIRUS INFECTION INHIBITOR, METHOD FOR INHIBITION OF INFECTION BY RNA VIRUS, RNA VIRUS INFECTION-INHIBITING PRODUCT, AND USE AS RNA VIRUS INFECTION INHIBITOR | NSUN3, RNASEH1, RNASEL | TDP1 2770/4885TSHR 4066/4885ALDH1A1 2981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.